Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Canterbury Laboratories to test for synthetic cannabis

Canterbury Health Laboratories set to be first in NZ to test for controversial synthetic cannabis products


Canterbury Health Laboratories (CHL) is on track to being the first laboratory in New Zealand to able to screen for synthetic cannabis product “Kronic” at its toxicology laboratory.

CHL Senior toxicology scientist Grant Moore says CHL is working on developing a method to detect Kronic in urine, which is expected to be available soon.

The next step will be gaining accreditation. This will mean companies using CHL's workplace drug testing service will be able to test for this synthetic substance and depending on their individual health and safety policy, be able to use this information accordingly.

“We are still in the very early stages of being able to do this testing. Hopefully we can achieve this in the coming months, which will mean CHL will be the first laboratory in New Zealand to have this accreditation and the only one in New Zealand able to test for this synthetic compound,” Grant says.

Kronic is marketed as ‘legal weed’ but serious concerns have been raised after emergency departments around the country reported treating increasing numbers of people that have experienced adverse side effects as a result of smoking the product.

Christchurch Hospital Emergency Department specialist Dr Paul Gee says the department has seen a concerning increase in cases arising from the use of ‘legal’ recreational drugs in the past 12 months. Users have been as young as 15 years old.

“Synthetic Cannabinoids are widely available as smoking mixtures and patients have begun to appear in the Emergency Departments with adverse effects,” Dr Gee says.

“There are dozens of synthetic chemicals in this class with some having potencies a hundred times that of botanic marijuana. Caution is advised as these drugs have not been tested for human consumption and safety concerns exist.”

Symptoms may include agitation, confusion, palpitations, drowsiness, seizures and coma.

Associate health minister Peter Dunne last week announced that laws giving the Government the power to curb the sale of synthetic cannabis product will be in place soon.


ends


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Fonterra: Canpac Site 'Resize' To Focus More On Paediatrics

Fonterra is looking at realigning its packing operations at Canpac, in the Waikato, to focus more on paediatric nutritionals... The proposed changes could mean around 110 roles may not be required at the site which currently employs 330. More>>

ALSO:

Scoop Business: Postie Plus Brand Gets 2nd Chance With Well-Funded Pepkor

The Postie Plus brand is getting a new lease of life after South Africa’s Pepkor bought the failed retailer’s assets out of administration and said it will use its purchasing power to reduce costs of stock and fatten margins. More>>

ALSO:

Warming: Warming Signs From State Of Climate Report

Climate data from air, land, sea and ice in 2013 'reflect trends of a warming planet' -- says the latest State of the Climate report, launched by U.S. and New Zealand scientists. More>>

ALSO:

Scoop Business: Embrace Falling Home Affordability, Says NZIER

Despair over the inability to afford a house is misplaced and should be embraced as an opportunity to invest in more wealth-creating activity, says the principal economist at the New Zealand Institute of Economic Research, Shamubeel Eaqub. More>>

Productivity Commission: NZ Regulation Not Keeping Pace

New Zealand regulators often have to work with out-of-date legislation, quality checks are under strain, and regulatory workers need better training and development. More>>

ALSO:

Callaghan Innovation: Investment To Help Deepen Innovation Reporting

Callaghan Innovation, the government’s high tech HQ for Kiwi business, is to help deepen New Zealand media coverage of the commercialisation of innovation through an arms-length partnership with independent business news service BusinessDesk. More>>

ALSO:

Tax Credits, Grants: Greens $1Bn R&D Plan

In the Party’s headline economic announcement, the Greens have launched their plan to build a smarter, more innovative economy which has as its centrepiece an additional $1 billion of government investment in research and development (R&D) above current spend, including tax breaks for business. More>>

ALSO:

Inflation: CPI Increases 0.3 Percent In June Quarter

The consumers price index (CPI) rose 0.3 percent in the June 2014 quarter, Statistics New Zealand said today. This follows rises of 0.3 percent the March quarter and 0.1 percent in the December 2013 quarter. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news